Supporting progress & translation of gene & cell therapies
The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.
The British Society for Gene and Cell Therapy (BSGCT) serves as a collaborative platform to advance Gene and Cell Therapy (GCT) in the UK.
We proactively foster cooperation among stakeholders, including the public, patients, scientists, companies, government, and media to support the optimal development of GCT technologies and therapies.
Our charity is managed by volunteer members via an Elected-Board and Sub-Committees. We rely on the crucial support of our sponsors and members and invite you to get involved.
BSGCT Blogs
Researcher Spotlight: Grace Rachel Humphreys
Biography: Grace is a final year BSc Medical Sciences and Engineering student at University College London (UCL) and is completing…
Could intranasal delivery improve COVID-19 vaccines?
By Daisy Adamson The COVID-19 pandemic resulted in the rollout of multiple effective vaccines including the Pfizer-BioNTech (BNT162b2) & Moderna…
A step in the right direction: A novel approach to gene therapy for Charcot-Marie-Tooth disease type 2
Author: Dr. Rebecca A Lea, University of Sheffield Charcot-Marie-Tooth (CMT) disease is an umbrella term that encompasses a broad range…